Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-03-22Clinical Trial Update: Nivolumab After Induction Treatment in Triple-negative Breast Cancer (TNBC) Patients [Phase 2]
Phase 2 clinical trial update evaluating nivolumab after induction treatment in triple-negative breast cancer patients.
-
CLINICAL_TRIALS trial_result · 2022-03-21Clinical Trial Update: Efficacy of Talazoparib in Asian Metastatic Breast Cancer Patients With a Homologous Recombinant Deficiency (HRD) Signature [Phase 2]
A Phase 2 clinical trial evaluating the efficacy of talazoparib in Asian patients with metastatic breast cancer characterized by homologous …
-
CLINICAL_TRIALS trial_result · 2022-03-21Clinical Trial Update: HR+/ HER2- Advanced/ Metastatic Breast Cancer Real World Treatment Patterns and Outcomes
A terminated clinical trial evaluating real-world treatment patterns and outcomes in HR+/HER2- advanced/metastatic breast cancer, with resul…
-
CLINICAL_TRIALS trial_result · 2022-03-16Clinical Trial Update: A Study of Palbociclib in Combination With Fulvestrant or Tamoxifen as Treatment for Metastatic Breast Cancer [Phase 2]
Phase 2 trial evaluating palbociclib with fulvestrant or tamoxifen in metastatic breast cancer (hormone receptor positive) has completed rec…
-
CLINICAL_TRIALS trial_result · 2022-03-16Clinical Trial Update: Neratinib in Treating Older Patients With Stage IV HER2-Positive Breast Cancer [Phase 2]
Phase 2 trial update of neratinib in older patients with stage IV HER2-positive breast cancer has completed; results posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-03-15Clinical Trial Update: Pembrolizumab in Combination With Paclitaxel in the Hormone Receptor-positive Metastatic Breast Cancer With High Tumor Mutational Burden Selected by Whole Exome Sequencing: Korean Cancer Study Group Trial (KCSG BR20-16) [Phase 2]
Phase 2 trial evaluating pembrolizumab with paclitaxel in hormone receptor-positive metastatic breast cancer selected for high tumor mutatio…
-
CLINICAL_TRIALS trial_result · 2022-03-15Clinical Trial Update: Lapatinib in Combination With Trastuzumab in Patients With HER2-Positive, Metastatic Breast Cancer [Phase 2]
Phase 2 study evaluating the combination of lapatinib with trastuzumab in HER2-positive metastatic breast cancer has completed. Results were…
-
CLINICAL_TRIALS trial_result · 2022-03-15Clinical Trial Update: Efficacy of Letrozole + Palbociclib Combination as Neoadjuvant Treatment of Stage II-IIIA PAM 50 ROR-defined Low or Intermediate Risk Luminal Breast Cancer, in Postmenopausal Women [Phase 2]
Phase 2 trial evaluating letrozole plus palbociclib as neoadjuvant therapy for postmenopausal women with stage II-IIIA luminal breast cancer…
-
CLINICAL_TRIALS trial_result · 2022-03-11Clinical Trial Update: Hypo Versus Conventional Fractionation in Reconstructed-Breast Cancer Mastectomy Patients [Phase 3]
Phase 3 trial comparing hypo-fractionation versus conventional fractionation in reconstructed breast cancer mastectomy patients; status not …
-
CLINICAL_TRIALS trial_result · 2022-03-10Clinical Trial Update: A Phase 1 Study Of Talazoparib, PARP Inhibitor, In Japanese Patients With Advanced Solid Tumors [Phase 1]
Phase 1 study of talazoparib in Japanese patients with advanced solid tumors has completed, with results posted in 2022 detailing initial sa…
-
CLINICAL_TRIALS trial_result · 2022-03-10Clinical Trial Update: Study of Radium-223 Dichloride in Combination With Exemestane and Everolimus Versus Placebo in Combination With Exemestane and Everolimus in Subjects With Bone Predominant HER2 Negative Hormone Receptor Positive Metastatic Breast Cancer [Phase 2]
Phase 2 trial comparing radium-223 dichloride with exemestane and Everolimus vs placebo with exemestane and Everolimus in bone-predominant H…
-
CLINICAL_TRIALS trial_result · 2022-03-09Clinical Trial Update: Pilot Study of the Effect of Duavee® on Benign Breast Tissue Proliferation [Phase 2]
Phase 2 pilot study evaluating the effect of Duavee on benign breast tissue proliferation; results posted after completion.
-
CLINICAL_TRIALS trial_result · 2022-03-08Clinical Trial Update: Bupropion Hydrochloride in Improving Sexual Desire in Women With Breast or Gynecologic Cancer [Phase 2]
Phase 2 clinical trial evaluating bupropion hydrochloride to improve sexual desire in women with breast or gynecologic cancers has completed…
-
CLINICAL_TRIALS trial_result · 2022-03-04Clinical Trial Update: Assessment of Cognitive Function After Surgery in Two Types of Anesthesia in Patients Operated for Breast Cancer [NA]
This clinical trial update reports results on cognitive function after breast cancer surgery using two types of anesthesia.
-
CLINICAL_TRIALS trial_result · 2022-03-03Clinical Trial Update: Gemcitabine Combined With Eribulin Regimen in the Treatment of Second-line Above Recurrent HER2-negative Breast Cancer [Phase 2]
Phase 2 trial evaluating gemcitabine in combination with eribulin for second-line HER2-negative breast cancer.
-
CLINICAL_TRIALS trial_result · 2022-03-02Clinical Trial Update: SPI-2012 vs Pegfilgrastim in the Management of Neutropenia in Participants With Breast Cancer With Docetaxel and Cyclophosphamide (ADVANCE) [Phase 3]
Phase 3 trial comparing SPI-2012 vs pegfilgrastim for neutropenia management in breast cancer patients receiving docetaxel and cyclophospham…
-
CLINICAL_TRIALS trial_result · 2022-03-02Clinical Trial Update: SPI-2012 vs Pegfilgrastim in Management of Neutropenia in Breast Cancer Participants With Docetaxel and Cyclophosphamide [Phase 3]
Phase 3 trial comparing SPI-2012 to Pegfilgrastim for neutropenia management in breast cancer patients receiving docetaxel and cyclophospham…
-
CLINICAL_TRIALS trial_result · 2022-02-25Clinical Trial Update: Window of Opportunity Trial of Dasatinib in Operable Triple Negative Breast Cancers With nEGFR [Phase 2]
Phase 2 window-of-opportunity trial evaluating dasatinib in operable triple-negative breast cancer; trial status terminated with results pos…
-
CLINICAL_TRIALS trial_result · 2022-02-25Clinical Trial Update: Dasatinib in Combination With Zoledronic Acid for the Treatment of Breast Cancer With Bone Metastasis [Phase 1, Phase 2]
Phase 1/2 trial investigating dasatinib combined with zoledronic acid for breast cancer with bone metastases; study completed with results p…
-
CLINICAL_TRIALS trial_result · 2022-02-25Clinical Trial Update: Safety and Efficacy of Toripalimab in HER2- Metastatic Breast Cancer Patients Treated With Metronomic Vinorelbine [Phase 2]
Phase 2 trial evaluating safety and efficacy of toripalimab in HER2-negative metastatic breast cancer patients treated with metronomic vinor…
-
CLINICAL_TRIALS trial_result · 2022-02-25Clinical Trial Update: Trial of Nivolumab With Chemotherapy as Neoadjuvant Treatment in Inflammatory Breast Cancer (IBC) [Phase 2]
Phase 2 trial evaluating nivolumab in combination with chemotherapy as neoadjuvant treatment for inflammatory breast cancer has completed wi…
-
CLINICAL_TRIALS trial_result · 2022-02-24Clinical Trial Update: Pyrotinib Plus Trastuzumab After First-line TH (P) Treatment With HER-2 Positive Breast Cancer [Phase 2]
Phase 2 clinical trial update evaluating pyrotinib plus trastuzumab after first-line therapy in HER-2 positive advanced breast cancer.
-
CLINICAL_TRIALS trial_result · 2022-02-24Clinical Trial Update: Phase I/II Study to Evaluate the Safety and Tolerability of LiPlaCis in Patients With Advanced or Refractory Tumours [Phase 1, Phase 2]
Phase I/II clinical trial evaluating the safety and tolerability of LiPlaCis in patients with advanced or refractory tumours; trial complete…
-
CLINICAL_TRIALS trial_result · 2022-02-23Clinical Trial Update: Chidamide Combined With Exemestane (+/- Goserelin) Versus Neoadjuvant Chemotherapy in Patients of Stage II-III HR-positive/HER2-negative Breast Cancer [Phase 2, Phase 3]
A clinical trial comparing chidamide plus exemestane (± goserelin) against neoadjuvant chemotherapy in stage II-III HR-positive/HER2-negativ…
-
CLINICAL_TRIALS trial_result · 2022-02-23Clinical Trial Update: Efficacy of Olanzapine, Netupitant and Palonosetron in Controlling Nausea and Vomiting Associated With Highly Emetogenic Chemotherapy in Patients With Breast Cancer [Phase 2]
Phase 2 trial evaluating olanzapine, netupitant, and palonosetron for controlling nausea and vomiting induced by highly emetogenic chemother…